North American Diagnostics, NAD was born out of the vast experience of accomplished in the world of science since 1990, a span of three decades. We attribute our success in Research and Development to the world class, guidance and leading-edge experiences
acquired as scientists at Pfizer, Inc working exclusively on Pfizer’s premiere pipeline of biologics and
devices in clinical research.
This experience laid a solid foundation for us to eventually consult in research and development for clients, viz. Pfizer, Novartis, Johnson & Johnson, Biogen, Glaxo-Wellcome, Boehringer Manheim, Sandoz,
Ciba, Bristol Myers Squibb, Amgen and Cyberonics, within Multi-Disciplinary Specialties including
Oncology, Neurological, Musculoskeletal, Infectious Disease, Cardiovascular, Endocrine; Biologics &
Device; phases 1 to 4.
Within the Nutraceutical arena, the team focuses heavily on extraction and formulation of Hemp based
products (oral, dermal & food) becoming a specialist and extraction formalist, manufacturing for national
brands. This has led to formulation and development of intellectual property related to novel Keto Weight
The Keto product launch is currently on-hold due to the unexpected need to develop testing devices for
Covid-19. The product has been manufactured in large quantity and will be backed by clinical trials, making
this the first clinical trial-based, plant based, weight loss product on the market. ESR, HbA1c and lipid
panel blood markers will be collected at baseline and completion.
Within the Lateral Flow Immunoassay arena, the company has will be launching an array of Viral Testing
kits in Q3/21 and an Anti-aging device with a complement of nutraceuticals in Q1/22.
North American Diagnostics, LLC is established for the sole purpose of researching, developing and
manufacturing Lateral Flow Antigen Test Devices, now manufactures and holds the Intellectual Property
rights and licensing to a highly sensitive SARS-CoV-2 Rapid Antigen Device & The Advanced Field
Diagnostics Transmission & Reporting System ™
The Oral Rapid SARS-CoV-2 Rapid Antigen Test Device has been awarded the CE Marking for a Medical
Device Certification authorized for sale and distribution in 31 countries in the European Union.
Paul currently leads a skilled team of scientists, manufacturing and administrative work force of 85 out of
the North American Diagnostics manufacturing plant in Daytona Beach, Florida, a truly American based
organization producing made in America products.
Currently, North American Diagnostics is focusing on its overseas sales, OTC studies with its overseas
brand and the submission of OTC & Provider data and to finalize the EUA process. Clinical trials of the company’s
plant based Diabetic medications is also being initiated.